Hassan Abdelhak: Understanding How LVADs Support the Failing Heart
Hassan Abdelhak, L-CRN CCL at King Salman Specialist Hospital, Taif, shared a post on LinkedIn:
“Understanding Left Ventricular Assist Devices (LVAD)
When advanced heart failure reaches stage D, traditional medical therapy often hits a wall. For patients awaiting a transplant – or those who aren’t candidates for one – a Left Ventricular Assist Device (LVAD) serves as a mechanical lifeline.
Understanding how an LVAD works!?
How an LVAD works: step-by-step
As shown in the diagram:
- Inflow (blood draw): Blood enters the mechanical pump directly from the left ventricle apex, bypassing the weakened native myocardium.
- Continuous-flow impeller: Inside the pump, a magnetic rotor spins continuously to generate uninterrupted forward blood flow without a traditional pulse.
- Outflow (systemic delivery): The device propels oxygenated blood into the ascending aorta, delivering vital perfusion throughout the body.
Key System Components Every Clinician Should Know
- The internal pump: Surgically implanted in the chest attached to the left ventricle and aorta.
- Driveline cable: Passes through the abdominal wall, connecting the internal pump to external components.
System controller: The ‘brain’ of the device, monitoring pump speed, flow rate, power usage, and alerting teams to alarms.
- Power source: External lithium-ion batteries worn on a shoulder harness or waist belt for mobility, or an AC power adapter during rest/sleep.
Primary clinical indications
- Bridge to transplant (BTT): Supports patients on the heart transplant waiting list until a donor organ becomes available.
- Destination therapy (DT): Provides long-term mechanical circulatory support for patients ineligible for heart transplantation due to age or comorbidities.
- Bridge to recovery (BTR): Serves as temporary support allowing the native myocardium to rest and potentially recover function.
Critical clinical and nursing care considerations
- Vascular assessment: Continuous-flow LVADs usually result in a non-pulsatile or weak pulse. Standard NIBP cuffs may not read correctly; mean arterial pressure (MAP) measured via Doppler ultrasound (target MAP: 70–80 mmHg) is the clinical standard.
- Driveline care: Strict aseptic technique during dressing changes is imperative to prevent driveline infections, the leading cause of morbidity in LVAD
patients.
Anticoagulation panagement: Patients require continuous anticoagulation (Warfarin) plus antiplatelet therapy to prevent pump thrombosis, balancing ischemic and hemorrhagic risks.
Emergency preparedness: Clinical teams must always ensure spare batteries and a backup system controller are at the bedside.
To my cardiology and CCU network: How does your institution manage long-term driveline care protocols and patient education for discharge readiness?”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?